Methylation-driven tumorigenic phenotypes have been best described in colorectal cancer (CRC) and prior studies have also demonstrated that UHRF1 plays a role in mediating these effects in CRC21,30,45. This evidence concerns the gene UHRF1 and colorectal carcinoma.